Homoeopathic treatment for post covid respiratory distress

A retrospective study to short list the different post covid complications in patient attending NIH IPD and OPD and role of homoeopathic medicine in combating post covid respiratory distress - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072297

Enrollment

Registered

2024-08-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J989- Respiratory disorder, unspecified Health Condition 2: J989- Respiratory disorder, unspecified Health Condition 3: J989- Respiratory disorder, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine in suitable potency: All patients will be prescribed individualized homoeopathic medicine after detailed case taking in accordance with the directio

Eligibility

Inclusion criteria

Inclusion criteria: History of COVID-19 (diagnosed by RTPCR or history of having COVID like manifestations). Patient suffering from respiratory distress which develops after Covid19.Age 18-65 years. Both sexes. Ability to understand Bengali or Hindi or English.

Exclusion criteria

Exclusion criteria: 1.Cases require immediate life support measures. 2.Cases suffering from uncontrolled systemic illness or life-threatening infections or any organ failure. 3.Patients who are too sick for consultation. 4.Unwilling to take part and not giving consent to join the study. 5.Diagnosed cases of unstable mental or psychiatric illness. 6.Pregnant women and lactating mothers 7.Substance abuse and/or dependence. 8.Self-reported immune-compromised state, and 9.Undergoing homoeopathic treatment for any other chronic disease within the last 6 months.

Design outcomes

Primary

Measure	Time frame
To assess the changes in intensity and duration of Post Covid respiratory distress after individualised Homoeopathic medication as per the direction of Hahnemann mentioned in Organon of Medicine in §104and §255.Timepoint: Baseline and 6 months	—

Secondary

Measure	Time frame
1.Modified Medical research Council (MRC) dyspnoea Scale 2.Modified Naranjo Criteria for Homoeopathy (MONARCH)Timepoint: Baseline and 6 months	—

Countries

India

Contacts

Public ContactProf Dr Subhas Singh

National Institute of Homoeopathy, Kolkata

drssubhas@gmail.com9830644223

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026